B7-H6/NCR3LG1, His, Human
B7-H6/NCR3LG1, His, Human

The purity of B7-H6/NCR3LG1, His, Human is greater than 95% as determined by SEC-HPLC.

B7-H6/NCR3LG1, His, Human

B7-H6/NCR3LG1, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

B7-H6/NCR3LG1, His, Human

Human NKp30, hFc Tag captured on CM5 Chip via Protein A can bind B7-H6/NCR3LG1, His, Human, His Tag with an affinity constant of 48.67 nM as determined in SPR assay (Biacore T200) (QC Test).

B7-H6/NCR3LG1, His, Human

B7-H6 is a glycosylated member of the B7 family of immune co‑stimulatory proteins. which is a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues.
Z05063
¥63,425.00

Ask us a question
Product Introduction
Species Human
Protein Construction
B7-H6/NCR3LG1 (Asp25-Ser262)
Accession # Q68D85-1		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Loaded Human NKp30, hFc Tag on Anti-His-Biosensor can bind B7-H6/NCR3LG1, His, Human. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 27.8 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-68 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • B7-H6/NCR3LG1, His, Human
    • B7-H6/NCR3LG1, His, Human

    The purity of B7-H6/NCR3LG1, His, Human is greater than 95% as determined by SEC-HPLC.

  • B7-H6/NCR3LG1, His, Human
    • B7-H6/NCR3LG1, His, Human

    B7-H6/NCR3LG1, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

  • B7-H6/NCR3LG1, His, Human
    • B7-H6/NCR3LG1, His, Human

    Human NKp30, hFc Tag captured on CM5 Chip via Protein A can bind B7-H6/NCR3LG1, His, Human, His Tag with an affinity constant of 48.67 nM as determined in SPR assay (Biacore T200) (QC Test).


Background
Target Background B7-H6 is a glycosylated member of the B7 family of immune co‑stimulatory proteins. which is a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues.
Synonyms B7H6; B7-H6; DKFZp686I21167; DKFZp686O24166; NCR3LG1; B7 Homolog 6

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.